Primer: Pharmala Biotech Holdings (MDMA CN) - Aug 2026
PharmAla is strategically positioned as a key supplier of clinical-grade MDMA (LaNeo), addressing a critical bottleneck for researchers and...
96 Views
𝛼SK or SearchENTITY
Pharmala Biotech Holdings (MDMA CN)
Pharmala Biotech Holdings (MDMA CN)
8
Analysis
Health Care • Canada
Pharmala Biotech Holdings Inc. operates as a biotech company. The Company focuses on domestic research, development, and manufacturing of clinical-grade MDMA and novel MDXX compounds in service to the scientific research community. Pharmala Biotech Holdings serves customers worldwide.
morex